"The Most Critical Metal for Global Economies"
The soaring demand for this "red rock" may be the most important development in 2022. It's key in the transition to the new green energy economies. Bloomberg News warns… "Within a decade, the world may face a massive shortfall of what's arguably the most critical metal for global economies." Copper prices have nearly doubled in the past year.
Find Out How This Is Good News

TLT Insider Trading (Theralase Technologies)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$56,430.00
Insider Selling (Last 12 Months): C$0.00

Theralase Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at Theralase Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Theralase Technologies Share Price & Price History

Current Price: C$0.28
Price Change: Price Decrease of -0.01 (-3.45%)
As of 05/16/2022 03:33 PM ET

This chart shows the closing price history over time for TLT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

Theralase Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/18/2022Roger John Dumoulin-WhiteDirectorBuy32,000C$0.32C$10,240.007,576,387
4/6/2022Roger John Dumoulin-WhiteDirectorBuy20,000C$0.32C$6,300.007,544,387
12/16/2021Roger John Dumoulin-WhiteDirectorBuy33,300C$0.30C$9,990.007,524,387
10/1/2021Roger John Dumoulin-WhiteDirectorBuy50,000C$0.20C$10,000.007,491,087
9/22/2021Kristina Maria HacheySenior OfficerBuy50,000C$0.20C$10,000.001,756,267
9/10/2021Roger John Dumoulin-WhiteDirectorBuy45,000C$0.22C$9,900.007,441,087
5/4/2021Roger John Dumoulin-WhiteDirectorBuy50,000C$0.21C$10,500.007,396,087
5/3/2021Kristina Maria HacheySenior OfficerBuy90,000C$0.22C$19,800.001,706,267
4/30/2021Arkady MandelSenior OfficerBuy60,000C$0.24C$14,100.0060,000
4/19/2021Roger John Dumoulin-WhiteDirectorBuy65,500C$0.25C$16,375.007,341,587
2/25/2021Roger John Dumoulin-WhiteDirectorBuy10,000C$0.28C$2,800.007,276,087
2/17/2021Roger John Dumoulin-WhiteDirectorBuy30,500C$0.25C$7,625.007,266,087
1/28/2021Roger John Dumoulin-WhiteDirectorBuy45,500C$0.22C$10,010.007,235,587
1/18/2021Guy John AndersonDirectorBuy27,777C$0.18C$4,999.86213,777
9/25/2020Roger John Dumoulin-WhiteDirectorBuy33,000C$0.16C$5,280.007,190,087
9/15/2020Roger John Dumoulin-WhiteDirectorBuy29,000C$0.17C$4,930.007,157,087
7/31/2020Roger John Dumoulin-WhiteDirectorBuy62,500C$0.16C$10,000.007,128,087
7/22/2020Roger John Dumoulin-WhiteDirectorBuy48,000C$0.21C$10,080.007,065,587
6/15/2020Roger John Dumoulin-WhiteDirectorBuy43,500C$0.23C$10,005.007,017,587
6/2/2020Roger John Dumoulin-WhiteDirectorBuy40,000C$0.25C$10,000.006,974,087
5/1/2020Roger John Dumoulin-WhiteDirectorBuy48,000C$0.21C$10,080.006,934,087
4/22/2020Roger John Dumoulin-WhiteDirectorBuy60,000C$0.18C$10,500.006,886,087
4/8/2020Roger John Dumoulin-WhiteDirectorBuy45,400C$0.22C$9,988.006,826,087
4/1/2020Roger John Dumoulin-WhiteDirectorBuy2,500C$0.18C$450.006,780,687
3/17/2020Roger John Dumoulin-WhiteDirectorBuy53,000C$0.19C$10,070.006,778,187
2/18/2020Roger John Dumoulin-WhiteDirectorBuy38,500C$0.26C$10,010.006,725,187
1/28/2020Roger John Dumoulin-WhiteDirectorBuy34,000C$0.30C$10,030.006,686,687
12/19/2019Roger John Dumoulin-WhiteDirectorBuy32,500C$0.32C$10,400.006,652,687
11/19/2019Roger John Dumoulin-WhiteDirectorBuy45,000C$0.23C$10,125.006,620,187
10/18/2019Roger John Dumoulin-WhiteDirectorBuy45,000C$0.21C$9,450.006,575,187
See Full Table
The Last Great Value Stock
Last year it was more profitable than Disney, Square or even Tesla. But it's just under $2 per share.

This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.

Check out the free presentation by clicking here.
>>>

SEC Filings (Institutional Ownership Changes) for Theralase Technologies (CVE:TLT)

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer. Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories. The company has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. It sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada.
Read More on Theralase Technologies

Today's Range

Now: C$0.28
Low: C$0.28
High: C$0.30

50 Day Range

MA: C$0.36
Low: C$0.25
High: C$0.47

52 Week Range

Now: C$0.28
Low: C$0.17
High: C$0.48

Volume

23,094 shs

Average Volume

215,276 shs

Market Capitalization

C$57.20 million

P/E Ratio

N/A

Dividend Yield

2.03%

Beta

N/A

Who are the company insiders with the largest holdings of Theralase Technologies?

Theralase Technologies' top insider shareholders include:
  1. Roger John Dumoulin-White (Director)
  2. Kristina Maria Hachey (Senior Officer)
  3. Guy John Anderson (Director)
  4. Arkady Mandel (Senior Officer)
Learn More about top insider investors at Theralase Technologies.
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.